Recommended Maintenance and Maximum Dosages for Glycemic Control The recommended maintenance dosage is 0.5 mg, 1 mg, or 2 mg, injected subcutaneously once weekly, based on glycemic control
Indigestion: Dyspepsia, or indigestion, is another side effect that can cause discomfort in the upper abdomen
GFR was estimated from creatinine by the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation ( build 37/hg19)
A variety of shorter circuits start from Barbury Castle on the Marlborough Downs and from White Horse Hill on the Calstone and Cherhill Downs
By performing a GWAS in the tirzepatide-treated population alone (Supplementary Table 12), we identified an association between the vomiting side effect and GIPR (rs71338792, P = 4.2 10 9 , odds ratio = 1.84